story of the week
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer
JAMA Oncol 2021 Jul 08;[EPub Ahead of Print], T Goshen-Lago, I Waldhorn, R Holland, M Szwarcwort-Cohen, A Reiner-Benaim, Y Shachor-Meyouhas, K Hussein, L Fahoum, M Baruch, A Peer, Y Reiter, R Almog, M Halberthal, I Ben-AharonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.